Subscribe to the Novartis Oncology RSS Newsfeed to Receive Novartis Oncology Press Releases http://www.novartisoncology.com <![CDATA[Phase III study shows Novartis drug Afinitor® more than doubles time without tumor growth in advanced pancreatic NET patients]]> 2010-07-01T07:15:00 CET http://www.novartisoncology.com/media/press-releases.jsp?id=1428793&year=2010 <![CDATA[FDA approves Tasigna® for newly diagnosed chronic myeloid leukemia patients, data demonstrate major advance over Glivec®]]> 2010-06-18T00:15:56 CET http://www.novartisoncology.com/media/press-releases.jsp?id=1424982&year=2010 <![CDATA[Study at ASCO shows Novartis drug Afinitor® first to shrink SEGA brain tumors in children and adults with tuberous sclerosis]]> 2010-06-05T23:30:00 CET http://www.novartisoncology.com/media/press-releases.jsp?id=1421888&year=2010 <![CDATA[Adding Novartis drug Zometa® to chemotherapy significantly improved overall survival in study of newly diagnosed multiple myeloma patients]]> 2010-06-05T14:15:00 CET http://www.novartisoncology.com/media/press-releases.jsp?id=1421887&year=2010 <![CDATA[New data at ASCO show Novartis drug Tasigna® surpasses Glivec® in slowing disease progression for newly diagnosed CML patients]]> 2010-06-04T07:15:00 CET http://www.novartisoncology.com/media/press-releases.jsp?id=1421566&year=2010 <![CDATA[Pivotal Phase III trial of Novartis drug Afinitor® met primary endpoint in study of patients with advanced pancreatic neuroendocrine tumors ]]> 2010-06-03T07:15:00 CET http://www.novartisoncology.com/media/press-releases.jsp?id=1421290&year=2010 <![CDATA[Data at ASCO show promise of Novartis drugs for patients with life-threatening diseases like CML, multiple myeloma and breast cancer]]> 2010-06-02T07:15:00 CET http://www.novartisoncology.com/media/press-releases.jsp?id=1420819&year=2010 <![CDATA[Novartis drug Tasigna® receives FDA priority review for newly diagnosed patients with early-stage chronic myeloid leukemia]]> 2010-02-19T07:15:00 CET http://www.novartisoncology.com/media/press-releases.jsp?id=1386313&year=2010 <![CDATA[Three new Novartis medicines approved in Japan for patients with type 2 diabetes, high blood pressure and advanced kidney cancer]]> 2010-01-20T07:15:00 CET http://www.novartisoncology.com/media/press-releases.jsp?id=1375090&year=2010 <![CDATA[Novartis Tasigna® trial shows superior results to Glivec® in patients with early-stage chronic myeloid leukemia]]> 2009-12-08T14:30:00 CET http://www.novartisoncology.com/media/press-releases.jsp?id=1359764&year=2009